C51.9 Malignant neoplasm, vulva, unspecified - analogs
| Description «C51.9 Malignant neoplasm, vulva, unspecified» | ||||||
|
||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 30% Compare C51 Malignant neoplasm of vulva
- 20% Compare C57.9 Malignant neoplasm, female genital organ, unspecified
- 15% Compare C52 Malignant neoplasm of vagina
- 13% Compare C57 Malignant neoplasm of other and unspecified female genital organs
- 13% Compare C57.8 Malignant neoplasm, overlapping lesion of female genital organs
- 13% Compare C57.7 Malignant neoplasm, other specified female genital organs
- 10% Compare C67.9 Malignant neoplasm, bladder, unspecified
- 10% Compare C34.1 Malignant neoplasm, upper lobe, bronchus or lung
- 10% Compare D13.4 Benign neoplasm, liver
- 10% Compare C34.9 Malignant neoplasm, bronchus or lung, unspecified
- 10% Compare E88.3 Tumour lysis syndrome
- 10% Compare C71.8 Malignant neoplasm, overlapping lesion of brain
- 10% Compare C22.0 Malignant neoplasm, liver cell carcinoma
- 10% Compare C22.9 Malignant neoplasm, liver, unspecified
- 10% Compare C77 Secondary and unspecified malignant neoplasm of lymph nodes
- 10% Compare C54.1 Malignant neoplasm, endometrium
- 10% Compare C18.3 Malignant neoplasm, hepatic flexure
- 10% Compare C94 Other leukaemias of specified cell type
- 10% Compare C91.9 Lymphoid leukaemia, unspecified
- 10% Compare D29.0 Benign neoplasm, penis
- 10% Compare C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum
- 10% Compare C92.5 Acute myelomonocytic leukaemia
- 10% Compare C67 Malignant neoplasm of bladder
- 10% Compare C41.0 Malignant neoplasm, bones of skull and face
- 10% Compare C71 Malignant neoplasm of brain
- 10% Compare C24.0 Malignant neoplasm, extrahepatic bile duct
- 10% Compare C76-C80 Malignant neoplasms of inaccurately designated, secondary and unspecified localizations
- 10% Compare C38.1 Malignant neoplasm, anterior mediastinum
- 10% Compare C94.2 Acute megakaryoblastic leukaemia
- 10% Compare C92.4 Acute promyelocytic leukaemia [PML]
- 10% Compare C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites
- 10% Compare C40 Malignant neoplasm of bone and articular cartilage of limbs
- 10% Compare C22.7 Malignant neoplasm, other specified carcinomas of liver
- 10% Compare C30.0 Malignant neoplasm, nasal cavity
- 10% Compare C32 Malignant neoplasm of larynx
- 10% Compare C77.3 Secondary and unspecified malignant neoplasm, axillary and upper limb lymph nodes
- 10% Compare C91 Lymphoid leukaemia
- 10% Compare C15.4 Malignant neoplasm, middle third of oesophagus
- 10% Compare C38.3 Malignant neoplasm, mediastinum, part unspecified
- 10% Compare C95.0 Acute leukaemia of unspecified cell type
- 10% Compare C40.9 Malignant neoplasm, bone and articular cartilage of limb, unspecified
- 10% Compare C49.4 Malignant neoplasm, connective and soft tissue of abdomen
- 10% Compare C93.0 Acute monoblastic/monocytic leukaemia
- 10% Compare C15.5 Malignant neoplasm, lower third of oesophagus
- 10% Compare C70.0 Malignant neoplasm, cerebral meninges
- 10% Compare C41.4 Malignant neoplasm, pelvic bones, sacrum and coccyx
- 10% Compare C74.9 Malignant neoplasm, adrenal gland, unspecified
- 10% Compare C50.0 Malignant neoplasm, nipple and areola
- 10% Compare C49.0 Malignant neoplasm, connective and soft tissue of head, face and neck
- 10% Compare C13.8 Malignant neoplasm, overlapping lesion of hypopharynx
Learn more about the selection of analogues
▶
- Medical online service designed to help in differential diagnostics.
- Find similar diseases for a diagnosis that causes irritation.
- If you are a professional, then the help of artificial intelligence will help in the express diagnostics.
The advantage of Kiberis is its versatility, thanks to which it is able to select analogues for anything, including for diseases and diagnoses. Artificial intelligence analyzes descriptions of diseases, clinical recommendations for their treatment, real statistics on making diagnoses and displays the most similar diseases with a degree of similarity in percent.